Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Pfizer
M.D. Anderson Cancer Center
University of Florida
Essen Biotech
University of Salamanca
Cancer Research UK
Washington University School of Medicine
Washington University School of Medicine
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Eastern Cooperative Oncology Group
Blue Note Therapeutics
Pfizer
Celgene
University of Wisconsin, Madison
Shenzhen BinDeBio Ltd.
Butler Hospital
University of Kansas Medical Center
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
Novartis
Novartis
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Scripps Health
Amgen